Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $69,578 | 17 | 86.9% |
| Travel and Lodging | $5,371 | 21 | 6.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 1 | 3.7% |
| Unspecified | $1,376 | 1 | 1.7% |
| Food and Beverage | $734.12 | 24 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $29,552 | 22 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $11,044 | 7 | $0 (2018) |
| AMAG Pharmaceuticals, Inc. | $8,515 | 9 | $0 (2018) |
| Lundbeck LLC | $7,500 | 4 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $7,076 | 6 | $0 (2017) |
| Allergan, Inc. | $6,900 | 3 | $0 (2021) |
| Celgene Corporation | $3,000 | 1 | $0 (2018) |
| Mallinckrodt LLC | $2,380 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $1,376 | 1 | $0 (2018) |
| Par Pharmaceutical, Inc. | $1,358 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11,400 | 4 | Lundbeck LLC ($6,600) |
| 2020 | $2,100 | 2 | Allergan, Inc. ($2,100) |
| 2019 | $11,835 | 7 | Janssen Research & Development, LLC ($10,935) |
| 2018 | $29,031 | 29 | BioDelivery Sciences International, Inc. ($11,044) |
| 2017 | $25,693 | 22 | Janssen Research & Development, LLC ($18,617) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2021 | Lundbeck LLC | NORTHERA (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: NEUROLOGY | ||||||
| 05/04/2021 | Lundbeck LLC | NORTHERA (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: NEUROLOGY | ||||||
| 05/04/2021 | Lundbeck LLC | NORTHERA (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: NEUROLOGY | ||||||
| 04/08/2021 | Allergan, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| 05/30/2020 | Allergan, Inc. | NATRELLE (Device) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: PLASTICS | ||||||
| 05/20/2020 | Allergan, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 11/22/2019 | Lundbeck LLC | NORTHERA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: NEUROLOGY | ||||||
| 02/28/2019 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $10,197.82 | General |
| 02/28/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $40.96 | General |
| 02/09/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $581.52 | General |
| 02/09/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 02/09/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 02/09/2019 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 10/31/2018 | AMAG Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 10/31/2018 | AMAG Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $63.24 | General |
| 10/31/2018 | AMAG Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| 10/31/2018 | AMAG Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| 09/22/2018 | Mallinckrodt LLC | — | Consulting Fee | Cash or cash equivalent | $2,379.92 | General |
| 09/22/2018 | Teva Pharmaceuticals USA, Inc. | Fentora (Drug) | — | Cash or cash equivalent | $1,375.51 | Research |
| Study: Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program • Category: Central Nervous System | ||||||
| 09/22/2018 | Par Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 09/22/2018 | Sentynl Therapeutics, Inc. | Abstral (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Pharmacology/Toxicology | ||||||
| 09/22/2018 | Par Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $14.63 | General |
| 09/22/2018 | Sentynl Therapeutics, Inc. | Abstral (Drug) | Travel and Lodging | Cash or cash equivalent | $14.63 | General |
| Category: Pharmacology/Toxicology | ||||||
| 09/22/2018 | Par Pharmaceutical, Inc. | — | Food and Beverage | Cash or cash equivalent | $4.33 | General |
| 09/22/2018 | Par Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $3.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) program | Teva Pharmaceuticals USA, Inc. | $1,376 | 1 |
About Dr. Brian Strom, MD
Dr. Brian Strom, MD is a Internal Medicine healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922035831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Strom, MD has received a total of $80,058 in payments from pharmaceutical and medical device companies, with $11,400 received in 2021. These payments were reported across 64 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($69,578).
Practice Information
- Specialty Internal Medicine
- Location Philadelphia, PA
- Active Since 06/27/2006
- Last Updated 09/17/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1922035831
Products in Payments
- BUNAVAIL 2.1 mg 30-count box (Drug) $11,044
- NORTHERA (Drug) $7,500
- Gadavist (Drug) $7,076
- Fentora (Drug) $1,376
- Abstral (Drug) $1,358
- NATRELLE (Device) $900.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Philadelphia
Pitamber Devgon, Md, MD
Internal Medicine — Payments: $7.5M
Dr. David Horn, M.d, M.D
Internal Medicine — Payments: $1.7M
Daniel Rader, Md, MD
Internal Medicine — Payments: $1.6M
Corey Langer, Md, MD
Internal Medicine — Payments: $742,647
Dr. Intekhab Ahmed, M.d, M.D
Internal Medicine — Payments: $621,997
David Goldmann, Md, MD
Internal Medicine — Payments: $587,696